Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BHST

BioHarvest Sciences Inc

Nov 12 • 04:00PM ET

7.90

+1.02 14.83 %

Consumer Defensive • Packaged Foods • Canada • NASD

Index	-	P/E	-	EPS (ttm)	-0.70	Insider Own	22.23%	Shs Outstand	17.33M	Perf Week	-10.73%
Market Cap	174.42M	Forward P/E	-	EPS next Y	-0.03	Insider Trans	0.00%	Shs Float	13.92M	Perf Month	-34.33%
Enterprise Value	193.33M	PEG	-	EPS next Q	-0.12	Inst Own	1.38%	Short Float	0.34%	Perf Quarter	-14.29%
Income	-12.06M	P/S	5.78	EPS this Y	29.06%	Inst Trans	11.46%	Short Ratio	0.61	Perf Half Y	19.70%
Sales	30.19M	P/B	-	EPS next Y	94.27%	ROA	-44.02%	Short Interest	0.05M	Perf YTD	27.83%
Book/sh	-0.24	P/C	46.76	EPS next 5Y	-	ROE	-973.22%	52W High	12.80 -38.28%	Perf Year	40.82%
Cash/sh	0.17	P/FCF	-	EPS past 3/5Y	-0.33% 45.00%	ROIC	-112.81%	52W Low	4.72 67.24%	Perf 3Y	4.28%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	128.83% 158.55%	Gross Margin	58.02%	Volatility	19.06% 12.65%	Perf 5Y	105.19%
Dividend TTM	-	EV/Sales	6.40	EPS Y/Y TTM	40.94%	Oper. Margin	-24.25%	ATR (14)	1.13	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.36	Sales Y/Y TTM	57.83%	Profit Margin	-39.95%	RSI (14)	40.88	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.60	EPS Q/Q	-460.48%	SMA20	-17.78%	Beta	1.25	Target Price	14.67
Payout	-	Debt/Eq	-	Sales Q/Q	41.28%	SMA50	-18.52%	Rel Volume	1.29	Prev Close	6.88
Employees	87	LT Debt/Eq	-	Earnings	Nov 13 AMC	SMA200	6.59%	Avg Volume	76.79K	Price	7.90
IPO	Mar 08, 2019	Option/Short	No / Yes	EPS/Sales Surpr.	-118.18% -0.21%	Trades		Volume	97,476	Change	14.83%

Date	Action	Analyst	Rating Change	Price Target Change
May-05-25	Initiated	Craig Hallum	Buy	$15
Dec-18-24	Initiated	Maxim Group	Buy	$12

Nov-12-25 05:25PM	Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates (Zacks) +14.83%
08:42AM	BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025 (Newsfile)
Nov-10-25 04:18PM	BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares (Newsfile) -5.88%
08:15AM	Compugen (CGEN) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-07-25 07:30AM	BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock (Newsfile) -8.94%
08:00PM	Loading…
Nov-06-25 08:00PM	Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -11.53%
04:37PM	BioHarvest Announces Proposed Public Offering of Common Stock (Newsfile)
Nov-04-25 07:30AM	BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time (Newsfile) -6.81%
Nov-03-25 09:37PM	BioHarvest Sciences (BHST) Announces Strategic CDMO Agreement With Saffron Tech (Insider Monkey)
05:35PM	Halozyme Therapeutics (HALO) Beats Q3 Earnings and Revenue Estimates (Zacks)
Oct-30-25 07:30AM	BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis (Newsfile)
Sep-22-25 06:32AM	BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction (Newsfile)
Sep-10-25 07:00AM	BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale (Newsfile)
Sep-02-25 08:30AM	BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET (Newsfile)
Aug-13-25 08:00AM	Diamond Equity Research Releases Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST) (GlobeNewswire)
03:03AM	Loading…
Aug-12-25 03:03AM	BioHarvest Sciences Inc (BHST) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com)
Aug-11-25 06:55PM	BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:30AM	BioHarvest Sciences Reports Second Quarter 2025 Financial Results (Newsfile)
Aug-07-25 07:15PM	The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +8.15%
Aug-06-25 05:45PM	Sarepta Therapeutics (SRPT) Tops Q2 Earnings and Revenue Estimates (Zacks) +5.33%
Aug-04-25 08:30AM	BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time (Newsfile)
Jul-24-25 11:09AM	BioHarvest Sciences Inc. (BHST) Surges 5.6%: Is This an Indication of Further Gains? (Zacks) +7.68%
Jul-23-25 08:30AM	BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025 (Newsfile) +5.60%
Jun-04-25 07:00AM	BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles (Newsfile)
Jun-03-25 08:50AM	What Makes BioHarvest Sciences Inc. (BHST) a Good Fit for 'Trend Investing' (Zacks)
May-21-25 08:30AM	BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound (Newsfile)
08:00AM	Diamond Equity Research Releases Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST) (GlobeNewswire)
May-15-25 05:45PM	BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	BioHarvest Sciences Reports First Quarter 2025 Financial Results (Newsfile)
May-13-25 07:15AM	Adherex Technologies Inc. (FENC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
08:30AM	Loading…
May-12-25 08:30AM	BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company (Newsfile)
May-08-25 10:00AM	BioHarvest Sciences Inc. (BHST) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
08:15AM	Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-07-25 05:25PM	Adma Biologics (ADMA) Misses Q1 Earnings and Revenue Estimates (Zacks)
May-06-25 06:30PM	Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-01-25 08:30AM	BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time (Newsfile)
Apr-15-25 07:20AM	BioHarvest Sciences Inc. (BHST) Soars 5.2%: Is Further Upside Left in the Stock? (Zacks) -5.08%
Apr-10-25 10:10AM	Kymera Therapeutics (KYMR) Moves 13.8% Higher: Will This Strength Last? (Zacks)
Mar-31-25 08:54PM	BioHarvest Sciences Inc. (BHST) Q4 2024 Earnings Conference Call Transcript (Seeking Alpha) -5.57%
05:45PM	BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results (Newsfile)
Mar-26-25 08:10AM	Precision BioSciences (DTIL) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Mar-17-25 08:30AM	BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time (Newsfile)
Mar-06-25 08:30AM	BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025 (Newsfile)
Mar-04-25 08:30AM	BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells (Newsfile) +5.38%
Feb-18-25 08:30AM	BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD (Newsfile) +6.14%
Feb-12-25 08:30AM	BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18 (Newsfile)
Jan-22-25 07:00AM	OTC Markets Group Announces Quarterly Index Performance and Rebalancing (GlobeNewswire)
03:30AM	BioHarvest Announces Appointment of Sharon Malka to Board of Directors (Newsfile)
Jan-08-25 08:40AM	BioHarvest Issues Shareholder Letter and Provides Corporate Update (Newsfile)
Dec-11-24 01:00AM	Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology (Newsfile)
Dec-02-24 08:00AM	Diamond Equity Research Releases Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST, CNSX: BHSC) (GlobeNewswire)
Nov-25-24 04:05PM	BioHarvest Sciences Reports Third Quarter 2024 Financial Results (Newsfile)
03:30AM	BioHarvest Launches VINIA SuperFood Functional Tea Line (Newsfile)
Nov-21-24 08:30AM	BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024 (Newsfile)
Nov-18-24 08:30AM	BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time (Newsfile) +5.00%
Nov-12-24 08:30AM	BioHarvest Sciences Begins Trading on the Nasdaq Global Market (Newsfile)

BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm engages in botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions. It offers nutraceutical health and wellness products, which includes dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients. The company was founded on April 19, 2013 and is headquartered in Vancouver, Canada.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BHST

BioHarvest Sciences Inc

Upgrade your FINVIZ experience